Skip to content

WALLSTENT® Endoprosthesis H965404510Recalls & reported problems

Boston Scientific Corporation · Self-Expanding Stent · Class 2 · Implant

All models of WALLSTENT Endoprosthesis (18)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729204138), received between Sep 16, 2021 and Oct 18, 2023 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation, Positioning or Separation Problem1
  • Unsealed Device Packaging1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 18, 2023Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem

    REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 25SEP2023. IT WAS REPORTED THAT PARTIAL DEPLOYMENT OCCURRED. THE TARGET LESION WAS OCCLUDED WITH TUMOR COMPRESSION LOCATED IN THE SUPERIOR VENA CAVA. A 22X45/10FR UNI PLUS 75CM WALLSTENT ENDOPROSTHESIS STENT WAS ADVANCED FOR TREATMENT. HOWEVER, WHEN ATTEMPTED TO DEPLOY THE STENT, RESISTANCE WAS ENCOUNTERED, AND FOUND THE SHAPE OF THE STENT WAS NOT GOOD AND THE TIP COULD NOT BE FULLY OPENED. THE PROCEDURE WAS COMPETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT WAS STABLE. HOWEVER, RETURNED DEVICE REVEALED STENT WAS DAMAGED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17957779 ↗
  • MalfunctionSep 16, 2021Unsealed Device Packaging; Unsealed Device Packaging

    IT WAS REPORTED VIA MEDWATCH (B)(4) THAT THE DEVICE PACKAGING WAS DAMAGED. A 22X45/10FR WALLSTENT UNI STENT WAS SELECTED FOR USE. HOWEVER, UPON INSPECTION, IT WAS NOTED THAT THE OUTER PACKAGE AND THE INNER PACKAGE CONTAINING THE STENT WERE DAMAGED. THE DEVICE WAS UNUSABLE. NO FURTHER INFORMATION AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12485822 ↗

Other Prosthesis, tracheal, expandable devices

All Prosthesis, tracheal, expandable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page